SCHEMBL7976016

SCHEMBL7976016

CCCCC(OC(C)=O)C(C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc1ccccc1)c1ccc2c(c1)OCO2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERAP2 Q6P179 8/20 0.55
IL1RN P18510 7/20 0.55
ERAP1 Q9NZ08 7/20 0.55
LNPEP Q9UIQ6 3/20 0.52
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TACR1 P25103 6/20 0.49
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
POLB P06746 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
NFKB1 P19838 1/20 0.46
APEX1 P27695 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986614 0.91 MAPK1 (0.54) ERAP2ERAP1LNPEPMAPK1SMN1; SMN2
SCHEMBL7976001 0.91 ERAP2 (0.56) ERAP2IL1RNERAP1LNPEPMAPK1
SCHEMBL7990236 0.83 MAPK1 (0.53) ERAP2IL1RNERAP1MAPK1SMN1; SMN2
SCHEMBL7990814 0.82 MAPK1 (0.53) MAPK1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL8807886 0.81 MAPK1 (0.55) ERAP2ERAP1LNPEPMAPK1SMN1; SMN2
SCHEMBL7990465 0.81 MAPK1 (0.55) ERAP2ERAP1LNPEPMAPK1SMN1; SMN2
SCHEMBL7994217 0.81 MAPK1 (0.55) ERAP2ERAP1LNPEPMAPK1SMN1; SMN2
SCHEMBL7987378 0.80 MAPK1 (0.53) MAPK1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL7988051 0.79 SMN1; SMN2 (0.55) ERAP2IL1RNMAPK1SMN1; SMN2TACR1
SCHEMBL7987404 0.79 KMT2A (0.51) ERAP2IL1RNMAPK1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6288105-B1 COMPOUNDS SUCH AS (S)-2-(4-((2-AMINO-3-HYDROXY-1-OXOPROPYL)AMINO)PHENYL)-6-HYDRO XY-3-(3-METHOXY-4-(1-PYRROLIDINYLMETHYL)BENZYL)BENZO(B)THIOPHE NE ELI LILLY AND COMPANY 2001-09-11 US disclosed
US-6207686-B1 FOR THERAPY OF HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed
WO-1996015109-A1 ENDOTHELIN ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-05-23 WO disclosed